Stock listing

Euronext:SEQUA Sequana Medical N.V Aandeel

Home listing (Euronext) of Sequana Medical N.V

Follow Sequana Medical N.V into a list and get an email when it puts out news.

Share price · EURONEXT:SEQUA

€0.611 EUR 0.000 (0.0%)

Close on Nov 20, 2026

Past year +0.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€0.560 – €0.669 EURNov 20, 2026
Market cap
€47.76M EURAt the close on Nov 20, 2026 · price × 78.17M shares outstanding
52-week range
€0.460 – €0.865 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€0 EURMedian day 0 shares · 66 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Sequana Medical N.V logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:SEQUA · Home€0.611 EUR0.000 (0.0%)—€0.669€0.669€0.560€0.611Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:SEQUA · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.669€0.669€0.5600
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
€0.6110.0000.0%€0.611€0.611€0.6110
Ticker
Euronext:SEQUA
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

All Sequana Medical N.V news

Sequana Medical N.V on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
16 in the last 12 months · 25 in all · newest Jun 29, 2026 · oldest 2025
Decks
81 decks · latest January 2026

Where Sequana Medical N.V is listed

ListingExchangeCountryCurrency
Euronext:SEQUA · Home listing · This pageEuronextBelgiumEUR
Frankfurt:2SEFrankfurtGermanyEUR
gettex:2SEgettexGermanyEUR
OTC:SQNMFOTCUnited StatesUSD
LS Exchange:A2PD78LS ExchangeGermanyEUR
Lang & Schwarz:A2PD78Lang & SchwarzGermanyEUR
Aquis:SEQUABAquisUnited KingdomEUR
Aquis:SEQUABAquisUnited KingdomEUR
Stuttgart:2SEStuttgartGermanyEUR
Dusseldorf:2SEDusseldorfGermanyEUR
Munich:2SEMunichGermanyEUR

Valuation

balance Jun 30, 2025 · price Nov 20, 2026

Enterprise value
€81.85M EUR
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Sequana Medical N.V · EURONEXT:SEQUAUS$52.42MUS$89.83Mn/an/an/an/an/an/an/a
P&S Robotics Co., Ltd. · KRX:460940US$54.38MUS$33.62M26.6×5.9×36.6×1.7×36.0%0.0×n/a
Creo Medical Group PLC · LSE:CREOUS$54.06MUS$49.48M7.8×6.3×n/a0.9×88.3%0.1×n/a
Crystalvue Medical Co Ltd · TPEX:6527US$53.82MUS$52.19M12.1×1.8×8.7×1.7×15.5%0.0×n/a
3D Global Biotech Inc. · TPEX:6808US$53.26MUS$38.17M26.4×6.1×17.5×2.4×32.2%0.0×n/a
Outset Medical, Inc. · NASDAQ:OMUS$53.03MUS$14.77Mn/a0.1×n/a0.6×−58.3%1.2×1.74
NeurAxis, Inc. · AMEX:NRXSUS$52.99MUS$48.80Mn/a7.5×n/a14.6×−185.2%0.1×1.77
Positron Corp. · OTC:POSCUS$52.29MUS$50.70Mn/a116×n/an/an/an/a0.36
BenQ Medical Technology Corp. · TPEX:4116US$52.13MUS$39.99M22.0×0.3×2.1×1.6×1.5%0.6×n/a
Envoy Medical, Inc. · NASDAQ:COCHUS$51.89MUS$38.10Mn/a165×n/an/an/an/a1.04
OSTEONIC Co., Ltd. · KRX:226400US$50.52MUS$37.57M6.7×1.0×3.8×0.9×20.0%0.1×n/a
Median of the othersUS$53.01MUS$39.08M17.0×6.0×8.7×1.6×17.8%0.1×1.39

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
1.50 EUR · Analysts' mean
EPS, year to Dec 2025
-0.41 · 2 analysts

Events

QuarterResultsShare move
Quarter to Dec 31, 2025Mar 25, 2026−1.2%
Quarter to Sep 30, 2025Dec 3, 2025−4.1%
Q2 2025Sep 25, 2025−12.9%
Quarter to Mar 31, 2025Apr 22, 2025+3.2%
Q4 2024Mar 18, 2025−19.5%
Q3 2024Nov 27, 2024−5.1%
Q2 2024Sep 30, 2024−34.7%
Q1 2024May 23, 2024 · Before open+4.7%
Q4 2023Mar 28, 2024−2.6%
Q3 2023Nov 29, 2023+7.7%
All 19 quarters
QuarterResultsShare move
Q2 2023Sep 14, 2023+7.4%
Q1 2023May 31, 2023−0.3%
Q4 2022Feb 8, 2023 · After close−5.8%
Q3 2022Nov 30, 2022−2.4%
Q2 2022Sep 8, 2022+3.3%
Q1 2022Apr 26, 2022 · After close−2.9%
Q3 2021Dec 1, 2021−0.6%
Q2 2021Sep 2, 2021 · Before open−5.2%
Q4 2020Mar 17, 2021 · Before open−0.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2026)Investor deck24 slidesJanuary 2026
Investor Presentation (November 2025)Investor deck25 slidesNovember 2025
Investor Presentation (September 2025)Investor deck25 slidesSeptember 2025
Investor Presentation (June 2025)Investor deck24 slidesJune 2025
Corporate Update (January 2025)Corporate update47 slidesJan 8, 2025
Investor Presentation (January 2025)Investor deck27 slidesJanuary 2025
Investor Presentation (May 2024)Investor deck25 slidesMay 2024
VFB Happening 2024Conference19 slidesMar 23, 2024
Investor Presentation (December 2023)Investor deck67 slidesDecember 2023
Investor Presentation (December 2023)Investor deck68 slidesDecember 2023
Show 50 decks
DeckKindSlidesDate
Finance Avenue 2023Conference23 slidesNov 18, 2023
VFB Biotech XL 2023Conference25 slidesNov 14, 2023
Investor Presentation (October 2023)Investor deck30 slidesOct 24, 2023
Corporate Update (October 2023)Corporate update33 slidesOct 19, 2023
Investor Presentation (October 2023)Investor deck68 slidesOctober 2023
H1 2023 Earnings PresentationEarnings15 slidesSep 14, 2023
Investor Presentation (September 2023)Investor deck56 slidesSeptember 2023
Investor Presentation (June 2023)Investor deck36 slidesJun 28, 2023
EASL Congress 2023Conference23 slidesJun 21, 2023
Investor Presentation (June 2023)Investor deck32 slidesJun 16, 2023
Investor Presentation (June 2023)Investor deck55 slidesJune 2023
VFB Happening 2023Conference28 slidesMar 25, 2023
BioCapital Europe 2023Conference21 slidesMar 3, 2023
Investor Presentation (March 2023)Investor deck38 slidesMar 2, 2023
Investor Presentation (March 2023)Investor deck31 slidesMarch 2023
FY2022 Earnings PresentationEarnings18 slidesFeb 9, 2023
Investor Presentation (February 2023)Investor deck52 slidesFebruary 2023
Investor Presentation (January 2023)Investor deck50 slidesJanuary 2023
Investor Presentation (December 2022)Investor deck27 slidesDecember 2022
Investor Presentation (November 2022)Investor deck34 slidesNov 17, 2022
Jefferies London Healthcare Conference 2022Conference21 slidesNov 17, 2022
Investor Presentation (November 2022)Investor deck48 slidesNovember 2022
Corporate Update (October 2022)Corporate update18 slidesOct 25, 2022
Investor Presentation (October 2022)Investor deck33 slidesOct 11, 2022
H1 2022 Earnings PresentationEarnings14 slidesSep 8, 2022
Investor Presentation (September 2022)Investor deck46 slidesSeptember 2022
Corporate Update (July 2022)Corporate update20 slidesJul 19, 2022
H.C. Wainwright Global Investment Conference (May 2022)Conference27 slidesMay 18, 2022
Needham Healthcare Conference, April 2022Conference27 slidesApr 13, 2022
FY2021 Earnings PresentationEarnings17 slidesApr 12, 2022
Investor Presentation (April 2022)Investor deck49 slidesApril 2022
Investor Presentation (April 2022)Investor deck47 slidesApril 2022
Oppenheimer Healthcare Conference 2022Conference27 slidesMar 17, 2022
H.C. Wainwright BioConnect Virtual Conference 2022Conference25 slidesJan 10, 2022
Investor Presentation (January 2022)Investor deck50 slidesJanuary 2022
Corporate Update (December 2021)Corporate update17 slidesDec 7, 2021
Finance Avenue 2021Conference27 slidesNov 20, 2021
Jefferies London Healthcare Conference 2021Conference28 slidesNov 16, 2021
Bolero Biotech event 2021Conference31 slidesOct 28, 2021
VFB Happening 2021Conference20 slidesOct 23, 2021

This page holds 50 of 81 decks. Open Decks

Open Decks

Financings

RaiseDate
New shares
Announced: raise
Buyers: GEM (to subscribe for between 50% and 150% of the Draw Down Amount of up to 2,999,900 new shares)
Feb 2, 2026
New shares
Closed: €0.5665 a share
Buyers: GEM Global Yield LLC SCS (1,243,695 new shares at EUR 0.5665 per share)
Jan 27, 2026
New shares
Closed: €0.7907 a share
Buyers: GEM (between a minimum of 50% and a maximum of 150% of the Draw Down Amount of up to 2,500,000 new shares); GEM Global Yield LLC SCS (2,614,848 new shares)
Oct 16, 2025
New shares
Announced: raise
Buyers: GEM (between 50% and 150% of the Draw Down Amount of up to 2,750,000 shares)
Oct 16, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in EUR

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue106.0K712.2K922.7K370.5K963.3K970.6K1.03M1.30M1.49M1.68M
Cost of revenue26.4K164.1K204.6K76.7K202.4K197.8K158.1K212.4K320.4K359.2K
Gross profit-2.22M548.0K718.1K293.8K760.9K772.9K871.1K1.09M1.17M1.33M
Research and development1.68M5.28M7.71M6.14M1.86M2.52M934.8K1.17M1.15M995.0K
Selling, general and administrative6.31M6.94M6.69M5.10M4.42M4.26M5.76M1.99M4.06M3.29M
Operating income-18.7M-28.9M-28.1M-22.6M-17.8M-14.1M-13.0M-7.57M-13.7M-11.4M
Depreciation and amortization615.0K661.3K311.5K408.5K306.5K244.1K22.0K77.9K80.1K46.5K
EBITDA-18.1M-28.2M-27.8M-22.2M-17.5M-13.8M-13.0M-7.49M-13.7M-11.4M
Interest expense26.4M4.29M2.73M854.5K1.35M770.6K922.0K635.5K190.1K88.5K
Income before tax-44.4M-32.1M-30.4M-23.2M-18.9M-14.8M-14.0M-8.21M-13.9M-11.5M
Income tax280.0K465.6K386.6K393.3K157.0K136.0K23.6K18.4K40.6K44.5K
Net income-44.7M-32.6M-30.8M-23.6M-19.1M-15.0M-14.0M-8.23M-14.0M-11.6M
Earnings per share, basic-1.22-1.22-1.35-1.30-1.25-1.22-1.02-0.60-1.02-0.85

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents3.81M2.58M18.9M9.60M11.0M5.59M1.32M1.68M797.5K1.43M
Receivables301.2K43.1K113.9K81.9K23.6K624.7K430.0K303.5K571.0K258.3K
Inventory2.05M2.30M2.62M2.14M1.47M1.60M1.24M1.27M1.96M2.14M
Current assets6.42M6.30M23.1M12.9M13.4M8.52M3.10M3.27M3.40M4.42M
Property, plant and equipment2.32M2.07M1.27M704.7K606.7K45.5K20.1K30.9K160.1K
Total assets9.94M10.1M26.0M14.7M14.2M9.35M3.34M3.52M3.81M4.68M
Accounts payable1.89M2.74M3.23M2.19M2.01M1.69M1.91M908.9K1.80M1.30M
Current liabilities53.2M19.5M15.1M7.18M5.97M5.31M18.7M5.55M4.84M4.12M
Long-term debt08.97M12.2M7.32M7.47M2.26M2.58M1.76M4.66M
Total debt40.1M16.8M16.7M7.32M7.47M3.22M14.7M4.58M4.66M
Total liabilities54.3M29.6M28.2M15.5M14.1M8.42M22.1M8.13M10.5M4.97M
Shareholders' equity-44.4M-19.5M-2.15M-786.9K112.8K925.9K-18.8M-4.61M-6.67M-284.7K
Shares outstanding36.6M26.8M22.8M18.2M15.3M12.3M13.7M13.7M13.7M13.7M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-20.3M-29.1M-27.5M-23.6M-17.0M-18.5M-9.88M-8.69M-12.7M-11.3M
Capital spending-95.0K-710.8K-676.7K-325.8K-138.0K-333.0K-38.6K-6.52K-214.7K-88.8K
Free cash flow-20.5M-29.8M-28.2M-23.9M-17.1M-18.8M-9.91M-8.70M-13.0M-11.3M
Cash from investing-100.0K-721.4K-653.1K-338.2K-142.0K-337.0K-54.9K-10.3K-217.0K-108.1K
Cash from financing21.6M13.5M37.3M22.4M22.6M23.2M9.47M9.81M12.2M8.22M
Share buybacks26.2M1.59K9.81M7.88M8.24M
Change in cash1.22M-16.3M9.19M-1.52M5.48M4.27M-366.1K886.4K-629.5K-2.66M

Open Financials

Cap table

Built by 6ix from Sequana Medical N.V’s releases · as of Feb 2, 2026

Common shares
78,172,033
Fully diluted
78,172,033

Fully diluted

LineShares
Common shares78,172,033

Share count over time

CountShares
Nov 22, 202678,172,033

Open Cap table

Log in to ask 6ix AI your own questions about Sequana Medical N.V.